SBI PO Notification 2025: SBI PO recruitment is being held for 541 vacancies, of which 500 are regular and 41 are backlog vacancies.

SBI PO notification 2025 has been released. A total of 541 vacancies have been notified. Graduates can apply for entry-level managerial position in the banking sector here.

The State Bank of India has launched its SBI PO 2025 recruitment drive, inviting applications for 541 vacancies until July 14. Candidates aged 21–30 with a graduate degree can apply via sbi.co ...

State Bank of India has announced the SBI PO 2025 recruitment, offering 541 Probationary Officer positions. The online application window is open until July 7, 2025, on sbi.co.in. Graduates aged 21-30 ...

Boost your IBPS PO 2025 preparation with the IBPS PO Free Mock Test. Attempt the All India Live Test for IBPS PO to improve speed and accuracy. Practice IBPS PO Free Mocks, Live Tests, and Quizzes.

Preparing for Bank PO 2025? This easy guide covers everything you need, from exam pattern and subject-wise tips to mock tests and interview strategy, to help you crack IBPS & SBI PO with ease.

Radosta's Po-Boys marks its 50th anniversary with its classic roast beef po-boys and a timeless feel. The restaurant quietly changed hands two years ago, yet the original family owners are still ...

SBI PO final result 2025: The State Bank of India (SBI) has officially declared the SBI Probationary Officer (PO) Final Result 2025 on June 13, shortlisting candidates for 600 prestigious PO ...

SBI PO Final Result 2025 out now! Download PDF with selected roll numbers. Check merit list, cutoffs, and next steps at sbi.co.in. 600 PO vacancies filled ...

U.S. Open 2025: Scottie Scheffler appeared as PO'd as you'll ever see him during post-round range session with swing coach ...

The 2026 Hyundai Ioniq 6 N is just around the corner, as the automaker today released several teaser photos. The images show the high-performance electric sedan's side profile, rear wing ...

Esther Rajavelu, Chief Executive Officer, Spero, said: “Achieving the primary endpoint in the PIVOT-PO trial marks a significant milestone for tebipenem HBr.